Cash Flow Cosmo Pharmaceuticals NV Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
0.00
146.00
-6.00
24.00
7.00
-2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
0.00
0.00
-13.00
-5.00
-5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-10.00
154.00
18.00
31.00
12.00
10.00
Cash Flow from Investing Activities
46.00
-122.00
50.00
0.00
23.00
79.00
Cash Flow from Financing Activities
-22.00
-38.00
-201.00
-41.00
-24.00
-8.00
Net Cash Inflow / Outflow
10.00
-5.00
-131.00
-12.00
13.00
80.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
0.00
0.00
-1.00
2.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CHF Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cosmo Pharmaceuticals NV
Figures in Million
consolidated Cash Flow Results
Change(CHF)
Change(%)
Profit Before Tax
-0.860412445438017
13590.0768365906
-13,590.00
-100.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.18959001210015
-2541.2878953781
2,537.00
99.84%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-10.8170152862747
15898.8285846792
-15,908.00
-100.07%
Cash Flow from Investing Activities
46.4200949729942
-4050.28139403888
4,096.00
101.15%
Cash Flow from Financing Activities
-22.919962898411
-12346.8389348321
12,324.00
99.81%
Net Cash Inflow / Outflow
10.843258803129
-19.9316697676714
29.00
154.40%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.83985798517955
478.360074424113
-479.00
-100.38%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -106.98% vs 732.12% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-10.82
154.93
-106.98%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
